Additive Lung Cancer Risk in Combined Interstitial Lung Abnormalities and Emphysema: Korean National Lung Cancer Screening Program

Abstract Rationale Interstitial lung abnormalities (ILA) and emphysema are frequently detected during lung cancer screening (LCS), but the impact of their coexistence—termed combined ILA and emphysema (CILAE)—on lung cancer risk remains unclear. Objectives To determine the prevalence of CILAE in a national LCS cohort, evaluate whether its effect on lung cancer risk is additive or multiplicative, and quantify its association with lung cancer incidence. Methods This retrospective cohort study analyzed data from the Korean national LCS program (2019–2020). Participants were categorized into four CT-defined groups: neither condition, emphysema alone, ILA alone, and CILAE. Lung cancer incidence rate ratios (IRRs) were calculated using the neither condition group as the reference. Cox proportional hazards regression, adjusted for demographic and clinical factors, assessed the interaction and risk associated with CILAE. Results Among 125600 participants, CILAE was present in 1.0% (1223/125600), ILA alone in 1.7% (2101/125600), and emphysema alone in 12.8% (16077/125600). Over a median follow-up of 2.8 years (95% confidence interval [CI]: 2.8, 2.9 years), lung cancer was diagnosed in 1.4% (1709/125600). Compared to neither condition, IRRs for lung cancer were 9.12 (95% CI: 7.39, 11.0) for CILAE, 4.51 (95% CI: 3.63, 5.44) for ILA alone, and 2.93 (95% CI: 2.66, 3.20) for emphysema alone. Adjusted HRs for lung cancer were 5.17 (95% CI: 4.21, 6.35; P<0.001) for CILAE, 3.10 (95% CI: 2.50, 3.84; P<0.001) for ILA alone, and 2.05 (95% CI: 1.83, 2.30; P<0.001) for emphysema alone. The interaction term between ILA and emphysema was not significant (adjusted hazard ratio [HR], 0.81; 95% CI: 0.60, 1.10; P=0.17), suggesting an additive rather than multiplicative effect. Conclusion CILAE was present in 1% of LCS participants and was associated with a lung cancer risk exceeding that of ILA or emphysema alone. The combined effect was additive rather than synergistic.

Authors

Institutions

Publication Details

Journal
Annals of the American Thoracic Society
Published
2026-01-23
DOI
https://doi.org/10.1093/annalsats/aaoaf068
Citations
1
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
36.44
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Additive Lung Cancer Risk in Combined Interstitial Lung Abnormalities and Emphysema: Korean National Lung Cancer Screening Program

Seung Ho Choi, Eunseo Jo, Saerom Kim, Jin Mo Goo et al.
1 citations
Annals of the American Thoracic Society
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
36.44
article

Additive Lung Cancer Risk in Combined Interstitial Lung Abnormalities and Emphysema: Korean National Lung Cancer Screening Program

Seung Ho Choi, Eunseo Jo, Saerom Kim, Jin Mo Goo, Yeun-Chung Chang, Christopher J Ryerson, Peter M George
article en
1 citations

Abstract

Abstract Rationale Interstitial lung abnormalities (ILA) and emphysema are frequently detected during lung cancer screening (LCS), but the impact of their coexistence—termed combined ILA and emphysema (CILAE)—on lung cancer risk remains unclear. Objectives To determine the prevalence of CILAE in a national LCS cohort, evaluate whether its effect on lung cancer risk is additive or multiplicative, and quantify its association with lung cancer incidence. Methods This retrospective cohort study analyzed data from the Korean national LCS program (2019–2020). Participants were categorized into four CT-defined groups: neither condition, emphysema alone, ILA alone, and CILAE. Lung cancer incidence rate ratios (IRRs) were calculated using the neither condition group as the reference. Cox proportional hazards regression, adjusted for demographic and clinical factors, assessed the interaction and risk associated with CILAE. Results Among 125600 participants, CILAE was present in 1.0% (1223/125600), ILA alone in 1.7% (2101/125600), and emphysema alone in 12.8% (16077/125600). Over a median follow-up of 2.8 years (95% confidence interval [CI]: 2.8, 2.9 years), lung cancer was diagnosed in 1.4% (1709/125600). Compared to neither condition, IRRs for lung cancer were 9.12 (95% CI: 7.39, 11.0) for CILAE, 4.51 (95% CI: 3.63, 5.44) for ILA alone, and 2.93 (95% CI: 2.66, 3.20) for emphysema alone. Adjusted HRs for lung cancer were 5.17 (95% CI: 4.21, 6.35; P<0.001) for CILAE, 3.10 (95% CI: 2.50, 3.84; P<0.001) for ILA alone, and 2.05 (95% CI: 1.83, 2.30; P<0.001) for emphysema alone. The interaction term between ILA and emphysema was not significant (adjusted hazard ratio [HR], 0.81; 95% CI: 0.60, 1.10; P=0.17), suggesting an additive rather than multiplicative effect. Conclusion CILAE was present in 1% of LCS participants and was associated with a lung cancer risk exceeding that of ILA or emphysema alone. The combined effect was additive rather than synergistic.

Annals of the American Thoracic Society
University of British Columbia (CA), National Taiwan University of Science and Technology (TW), National Taiwan University (TW), Cancer Research Institute (US), St. Paul's Hospital (CA), New Generation University College (ET), Seoul National University Hospital (KR), Royal Brompton Hospital (GB), Lung Institute (US), Chung Shan Medical University Hospital (TW), National Taiwan University Hospital (TW), Southerners on New Ground (US), St. Paul's Hospital (CA), Imperial College London (GB)
Good health and well-being
Openalex Percentile: Top 1%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
36.44
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.